STOCK TITAN
  1. Home
  2. Financials
  3. CNSP
  4. EPS (Diluted)

CNS Pharmaceuticals, Inc. (CNSP) EPS by Year

CNSP

CNS Pharmaceuticals, Inc. lost $0.04 per diluted share in fiscal year 2025. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters CNS Pharmaceuticals, Inc. has filed alongside them.

FY2025 annual
EPS (Diluted) -$0.04
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CNSP EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY25DEF 14AFY24DEF 14AFY23DEF 14AFY2210-KFY2110-KFY2010-KFY1910-KFY1810-K
EPS (Diluted)-$0.04-$0.47-$12.51-$11.22-$16.50N/AN/AN/A

CNSP EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
EPS (Diluted)-$0.38-$7.30-$10.15-$5.76-$6.42-$18.93-$37.33-$153.20-$4049.20-$1020.48-$12306.63-$54.14

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More CNS Pharmaceuticals, Inc. financials

Frequently Asked Questions

What was CNS Pharmaceuticals, Inc.'s diluted earnings per share in fiscal year 2025?

CNS Pharmaceuticals, Inc. lost $0.04 per diluted share in fiscal year 2025.

What was CNS Pharmaceuticals, Inc.'s diluted earnings per share in the most recent quarter?

CNS Pharmaceuticals, Inc. (CNSP) reported -$0.38 in diluted earnings per share in Q2 2026.

What does diluted earnings per share mean on a financial statement?

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what CNS Pharmaceuticals, Inc. (CNSP) reported on that line in every period on record.